A non-randomized phase II study of sequential irinotecan (CPT) and flavopiridol (F) in patients (pts) with advanced hepatocellular carcinoma (HCC) Meeting Abstract


Authors: Abou-Alfa, G. K.; Carvajal, R. D.; Chung, K. Y.; Ghossein, R. A.; Capanu, M.; Gonen, M.; Jacobs, G.; Kelsen, D. P.; Schwartz, G. K.
Abstract Title: A non-randomized phase II study of sequential irinotecan (CPT) and flavopiridol (F) in patients (pts) with advanced hepatocellular carcinoma (HCC)
Meeting Title: 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 24
Issue: 18 Suppl. Pt. 1
Meeting Dates: 2006 Jun 2-6
Meeting Location: Atlanta, GA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2006-06-01
Start Page: 214S
Language: English
ACCESSION: WOS:000239009401291
PROVIDER: wos
Notes: --- - Meeting Abstract: 4148 - 42nd Annual Meeting of the American-Society-of-Clinical-Oncology - JUN 02-06, 2006 - Atlanta, GA - S - Part 1 - "Source: Wos"
MSK Authors
  1. Gary Schwartz
    358 Schwartz
  2. Ronald A Ghossein
    296 Ghossein
  3. Mithat Gonen
    701 Gonen
  4. Ki Y Chung
    43 Chung
  5. Richard D Carvajal
    133 Carvajal
  6. Ghassan Abou-Alfa
    219 Abou-Alfa
  7. Marinela Capanu
    206 Capanu
  8. David P Kelsen
    332 Kelsen
  9. Gria N Jacobs
    8 Jacobs